Key result
Oral prednisone with BMS cuts percent stenosis ~30% vs control with improved healing.
Why the study?
Does oral prednisone combined with a bare-metal stent reduce neointimal formation and improve vessel healing compared to a paclitaxel-eluting stent or bare-metal stent alone in an atherosclerotic rabbit model?
RCT
Randomized
Does oral prednisone combined with a bare-metal stent reduce neointimal formation and improve vessel healing compared to a paclitaxel-eluting stent or bare-metal stent alone in an atherosclerotic rabbit model?
p-value: p=0.009
No takes yet. Share an insight, caveat, or question.
Systemic prednisone combined with a bare-metal stent reduces neointimal formation to a similar extent as a paclitaxel-eluting stent, but without the delayed healing and increased inflammation seen with the drug-eluting stent.
Ribichini et al. (2007) conducted an RCT in Established atherosclerosis. Oral prednisone and bare-metal stent vs. Bare-metal stent and placebo was evaluated on percent stenosis (p=0.009). Oral prednisone with a bare-metal stent reduced percent stenosis by 30% (p=0.009) and neointimal thickness by 66% (p<0.001) compared to control, with less delayed healing than Taxus stents.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: